Insider · CIK 0001632237

Benaim Ely

Reports to the SEC for 2 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001632237

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-06	NVCRNovoCure LtdA Award	Chief Medical Officer	AAward	+98 sh	$62.30	+$6,105.89	28,770
2022-08-03	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−563 sh	$71.09	−$40K	34,068
2022-08-03	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−5,396 sh	$74.00	−$399K	28,672
2022-08-02	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−437 sh	$69.66	−$30.4K	34,631
2022-07-05	NVCRNovoCure LtdA Award	Chief Medical Officer	AAward	+222 sh	$59.08	+$13.1K	35,068
2022-05-11	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−2,135 sh	$61.25	−$131K	34,846
2022-05-10	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−2,070 sh	$65.16	−$135K	36,981
2022-03-04	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−1,510 sh	$70.41	−$106K	43,257
2022-03-03	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Chief Medical Officer	AAward	+5,452 sh	$80.59	+$439K	5,452
2022-03-03	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Chief Medical Officer	AAward	+30.4K sh	$80.59	+$2.45M	30,422
2022-03-03	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−803 sh	$74.50	−$59.8K	44,767
2022-03-03	NVCRNovoCure LtdA Award	Chief Medical Officer	AAward	+17.4K sh	—	—	45,570
2022-01-06	NVCRNovoCure LtdA Award	Chief Medical Officer	AAward	+55 sh	$63.82	+$3,509.99	28,199
2021-08-03	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−464 sh	$150.11	−$69.7K	28,144
2021-08-02	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−536 sh	$149.38	−$80.1K	28,608
2021-07-30	NVCRNovoCure LtdM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+651 sh	$83.30	+$54.2K	29,795
2021-07-30	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−651 sh	$158.96	−$103K	29,144
2021-07-30	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−651 sh	—	—	3,253
2021-07-06	NVCRNovoCure LtdA Award	Chief Medical Officer	AAward	+90 sh	$137.12	+$12.3K	29,144
2021-05-27	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−1,833 sh	$200.00	−$367K	29,054
2021-05-27	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,833 sh	—	—	7,332
2021-05-27	NVCRNovoCure LtdM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,833 sh	$47.56	+$87.2K	30,887
2021-05-12	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−1,943 sh	$180.48	−$351K	29,054
2021-05-11	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−2,262 sh	$180.12	−$407K	30,997
2021-05-10	NVCRNovoCure LtdM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,833 sh	$47.56	+$87.2K	35,092
2021-05-10	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,833 sh	—	—	9,165
2021-05-10	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−1,833 sh	$189.65	−$348K	33,259
2021-04-13	NVCRNovoCure LtdM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+651 sh	$83.30	+$54.2K	33,910
2021-04-13	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−3,474 sh	$200.00	−$695K	33,259
2021-04-13	NVCRNovoCure LtdM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,474 sh	$69.37	+$241K	36,733
2021-04-13	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−651 sh	$200.00	−$130K	33,259
2021-04-13	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−1,833 sh	$200.00	−$367K	33,259
2021-04-13	NVCRNovoCure LtdM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,833 sh	$47.56	+$87.2K	35,092
2021-04-13	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,474 sh	—	—	19,404
2021-04-13	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−651 sh	—	—	3,904
2021-04-13	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,833 sh	—	—	10,998
2021-03-05	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−2,918 sh	$131.53	−$384K	33,259
2021-03-04	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−1,888 sh	$137.55	−$260K	36,177
2021-03-03	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,475 sh	—	—	22,878
2021-03-03	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−3,475 sh	$150.78	−$524K	38,065
2021-03-03	NVCRNovoCure LtdM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,475 sh	$69.37	+$241K	41,540
2021-03-02	NVCRNovoCure LtdA Award	Chief Medical Officer	AAward	+8,709 sh	—	—	38,065
2021-03-02	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Chief Medical Officer	AAward	+16K sh	—	—	16,003
2020-12-21	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−1,833 sh	$156.71	−$287K	29,356
2020-12-21	NVCRNovoCure LtdM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,833 sh	$47.56	+$87.2K	31,189
2020-12-21	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−651 sh	—	—	4,555
2020-12-21	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,833 sh	—	—	12,831
2020-12-21	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−651 sh	$156.71	−$102K	29,356
2020-12-21	NVCRNovoCure LtdM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+651 sh	$83.30	+$54.2K	30,007
2020-08-03	NVCRNovoCure LtdS Sale	Chief Medical Officer	SSale	−660 sh	$76.06	−$50.2K	29,356

Recent filings

Accepted (ET)
Jan 104
Benaim Ely0001645113-23-000012
SEC(opens sec.gov)
Aug 44
Benaim Ely0001645113-22-000073
SEC(opens sec.gov)
Aug 34
Benaim Ely0001645113-22-000070
SEC(opens sec.gov)
Jul 74
Benaim Ely0001645113-22-000061
SEC(opens sec.gov)
May 124
Benaim Ely0001645113-22-000046
SEC(opens sec.gov)
Mar 74
Benaim Ely0001645113-22-000017
SEC(opens sec.gov)
Jan 124
Benaim Ely0001645113-22-000006
SEC(opens sec.gov)
Aug 44
Benaim Ely0001645113-21-000095
SEC(opens sec.gov)
Aug 34
Benaim Ely0001645113-21-000094
SEC(opens sec.gov)
Jul 84
Benaim Ely0001645113-21-000085
SEC(opens sec.gov)
May 284
Benaim Ely0001645113-21-000069
SEC(opens sec.gov)

Companies

Address

C/O REXAHN PHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 455

ROCKVILLE, MD, 20850